Imatinib mesylate can induce molecular remissions in chronic myeloid leukemia

被引：0
|
作者：
Lawler, M
Gately, K
Ryan, J
Carroll, P
Howard, J
Stallings, R
Conneally, E
McCann, S
机构：
来源：
BONE MARROW TRANSPLANTATION | 2003年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S160 / S160
页数：1
相关论文
共 50 条
  • [41] Nutritional Status of Patients with Chronic Myeloid Leukemia Treated with Imatinib Mesylate
    Jose Castillo-Martinez, Maria
    Juventina Tuna-Aguilar, Elena
    del Pilar Milke-Garcia, Maria
    Camacho Zamora, Anais
    Villegas Cervantes, Viviana
    Castillo-Martinez, Lilia
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2022, 74 (09): : 3211 - 3216
  • [42] Imatinib mesylate-induced pseudoporphyria in a patient with chronic myeloid leukemia
    Batrani, Meenakshi
    Salhotra, Manish
    Kubba, Asha
    Agrawal, Manjul
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2016, 82 (06): : 727 - 729
  • [43] Immunomodulatory influence by interferon alpha and imatinib mesylate in chronic myeloid leukemia
    Yokoyama, Kazuaki
    Nagamura-Inoue, Tokiko
    Nakayama, Shin
    Ishige, Ikuo
    Ohno, Nobuhiro
    Takahashi, Satoshi
    Uchimaru, Kaoru
    Iseki, Toru
    Tojo, Arinobu
    BLOOD, 2007, 110 (11) : 205B - 205B
  • [44] Reversible skin telangiectasia induced by imatinib mesylate in chronic myeloid leukemia
    Turhan, Ali G.
    LEUKEMIA & LYMPHOMA, 2016, 57 (11) : 2731 - 2732
  • [45] IMATINIB MESYLATE IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA (CML) PATIENTS
    Ionita, H.
    Ionita, I.
    Cheveresan, M.
    Iordache, M.
    Cheveresan, L.
    Ionita, M.
    Borzak, G.
    Ionita, C. O.
    Pascalau, A.
    Calamar, D.
    Oros, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 548 - 548
  • [46] Imatinib mesylate in blastic phase of chronic myeloid leukemia: an Indian experience
    Mukhopadhyay, S
    Gupta, P
    Saha, K
    Barman, B
    Sen, A
    Mukhopadhyay, A
    ANNALS OF ONCOLOGY, 2005, 16 : 303 - 304
  • [47] Positive response to imatinib mesylate therapy for childhood chronic myeloid leukemia
    Oliveira, G. A. P.
    Costa, E. S.
    Freitas, M. S.
    Dutra, F. F.
    Maia, S. F.
    Guerra, M. C.
    Tabernero, M. D.
    Borojevic, R.
    Otazu, I. B.
    Silva, J. L.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2010, 43 (06) : 580 - 584
  • [48] Effects of Deeper Molecular Responses on Outcomes in Chronic Myeloid Leukemia Patients in Chronic Phase Treated With Imatinib Mesylate
    Atagunduz, Isik Kaygusuz
    Toptas, Tayfur
    Deniz, Rabia
    Kara, Osman
    Eser, All
    Sezgin, Aslihan
    Ozgumus, Toluy
    Gecgel, Fatma
    Tuglularl, Tulin Firatli
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (02): : 120 - 125
  • [49] Chronic myeloid leukemia arising from acute myeloid leukemia: response to imatinib mesylate with favorable outcome
    Xu, Xiao-Hua
    Huang, Lian-Sheng
    Yang, Jing
    Yu, Teng
    Tong, Jie-Feng
    Yuan, Xiang-Gui
    Zhao, Xiao-Ying
    LEUKEMIA & LYMPHOMA, 2013, 54 (01) : 195 - 197
  • [50] CLINICAL SIGNIFICANCE OF EARLY MOLECULAR RESPONSE IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED FRONTLINE WITH IMATINIB MESYLATE
    Castagnetti, F.
    Gugliotta, G.
    Breccia, M.
    Albano, F.
    Abruzzese, E.
    Levato, L.
    Cavazzini, F.
    Lurlo, A.
    Stagno, F.
    Ferrero, D.
    Porretto, F.
    Martino, B.
    Rupoli, S.
    Intermesoli, T.
    Fava, C.
    Pierri, I.
    Palandri, F.
    Venturi, C.
    Soverini, S.
    Luatti, S.
    Alimena, G.
    Pane, F.
    Martinelli, G.
    Saglio, G.
    Cavo, M.
    Baccarani, M.
    Rosti, G.
    HAEMATOLOGICA, 2013, 98 : 59 - 59
12345